Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Chicago
University of Chicago
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)